Faculty Profile

Address:
630 West 168th Street
Room 15-409
New York, NY 10032

Phone: 212-342-0546
Fax: 212-305-5498

rv2025@columbia.edu

Education and Training
Ph.D. 1974 Yale University

Affiliations
Stem Cell Consortium
Anatomy & Cell Biology
Center for Neurobiology & Behavior
Pathology

Training Activities
Integrated Program in Cellular, Molecular & Biophysical Studies
Doctoral Program in Neurobiology & Behavior
Training program in Anatomy & Cell Biology
MD/PhD Program


Richard Vallee, Ph.D.
Professor
of Pathology

Research Summary
Motor proteins in axonal transport, brain developmental disease, and synaptic function.

Dr. Vallee's Laboratory

Cytoplasmic dynein is a large microtubule motor protein which is responsible for retrograde axonal transport. It is also involved in neuronal migration, mitosis, secretion, endocytosis, nuclear migration, viral transport, and many other basic cellular processes.

Recent evidence has implicated cytoplasmic dynein in the "smooth brain" disease, lissencephaly, which arises from sporadic mutations at the LIS1 locus. This condition is thought to arise from a defect in the migration of neuronal/glial progenitor cells during early development. Neurons exhibit more-or-less normal differentiation, but are scattered randomly within an expanded cerebral cortex. We have found the LIS1 gene product to associate with cytoplasmic dynein directly. Surprisingly, the LIS1 protein colocalized with cytoplasmic dynein at mitotic kinetochores and the mitotic cell cortex. Interference with LIS1 expression of function caused dramatic changes in mitotic spindle orientation, chromosome behavior, and mitotic index. Together, these results suggested that mitotic or cell cycle defects might contribute to lissencephaly and other brain developmental abnormalities. In the case of lissencephaly, cell division defects could affect neuronal distribution indirectely by affecting the timing of neurogenesis.

We are also interested in determining whether LIS1 and, by extension, cytoplasmic dynein are directly involved in cell migration. To the end, we have begun to examine a number of neuronal and nonneuronal systems. We find that in wounded fibroblast monolayers, both cytoplasmic dynein and LIS1 redistribute prominently to the leading cell edge during migration. Inhibition of cytoplasmic dynein and LIS1 interfere with the reorientation of the microtubule network and forward cell movement. These results suggest that cytoplasmic dynein, regulated by LIS1, pulls on microtubules at the leading cell edge. We believe that one result of this activity is to ensure that the cytoskeleton and membranous organelles are carried forward. In addition, our results may reflect the operation of a novel tension-sensing mechanism, which dictates the direction of actomyosin-based lamellipodial activity.

Together with the laboratories of Drs. Arnold Kriegstein and Jim Goldman, we are setting up assays to test the role of cytoplasmic dynein and LIS1 in migration of neuronal/glial progenitor cells in brain slices and other preparations. We are also interested in defining the role of dynein and LIS1 in glioma cell migration, a serious problem in the control of brain cancer.

We are also interested in the basic mechanisms by which cytoplasmic dynein is selectively targeted to diverse subcellular organelles, how its activity is switched on and off during axonal transport and other functions, and how it produces force. The dynein motor domain is ten-fold larger than that of kinesin, and is thought to consist of a hexameric ring of six AAA ATPase units from which protrudes an unusual 10-12 nm microtubule-binding stalk. We are interested in determining the structure of the motor domain and its subdomains, in learning the role of the multiple ATPase modules, and in determining how conformational information is transmitted through the stalk to ATPase sites. Of considerable interest, the LIS1 protein associates with one of the AAA modules, suggesting that it may function by regulating motor activity.

Effect of dynactin disruption on dividing COS-7 cells. Cell at left is overexpressing the dynamitin subunit of the dynactin complex; cell at right is a non-expressing control. Blue, anti-dynamitin; green, anti-tubulin; red, CREST auto-immune anti-centromere. Dynactin overexpression inhibits mitosis during prometaphase and distorts the mitotic spindle (from Echeverri et al., 1996). A) Neuronal progenitor cells at progressive stages of development in the vertebrate ventricular zone. Aspects of cell motility potentially affected by LIS-1 mutations are shown. Apical (ventricular) surface at bottom. B and C) Dividing polarized MDCK epithelial cells examined by confocal anti-tubulin immunofluorescence microscopy. B) Control mitotic spindle lies parallel to coverslip, as shown. C) Mitotic spindle in LIS-1 overexpressing cell is misoriented. Regulation of spindle orientation by LIS1 is proposed to control affect the timing of neurogenesis in the developing brain and the subsequent destination of migrating neurons. (from Faulkner and Vallee, 2000).

Selected Publications

1. Gee, M.A., Heuser, J. E., and Vallee, R.B. (1997) An Extended Microtubule-binding Structure within the Dynein Motor Domain. Nature 390: 636-639.

2. Faulkner, N. E., Dujardin, D. L., Tai, C.-Y., Vaughan, K. T., O'Connell, C. B., Wang, Y.-L., and Vallee, R. B. (2000) A Role for the Lissencephaly Gene LIS-1 in Mitosis and Cytoplasmic Dynein Function. Nature Cell Biol. 2: 784-791.

3. Vallee, R. B., Tai, C.-Y., and Faulkner, N. E. (2001) LIS1: Cellular Function of a Disease-causing Gene. Trends Cell Biol. 11: 155-160.

4. Tai, C.-Y., Dujardin, D. L., Faulkner, N. E., and Vallee, R. B. (2002) Role of Dynein, Dynactin, and CLIP170 Interactions in LIS1 Kinetochore Function. J. Cell Biol. 156: 959-968.

5. Vallee RB, Hook P. Molecular motors: A magnificent machine. Nature. 2003 Feb 13;421(6924):701-2.

6. Dujardin, D. L., Barnard, L. E., Stehman, S. A., Gomes, E., Gundersen, G. G., and Vallee, R. B. (2003) A Role for Cytoplasmic Dynein and LIS1 in Directed Cell Movement. J. Cell Biol. 163:1205-1211.

Current Projects

1. Molecular genetics of cytoplasmic dynein
Cytoplasmic dynein is a minus end-directed microtubule motor protein. The aims of this grant are to understand the mechanism by which force is produced and the full scope of biological activities in which the protein is involved. Approaches ranging from live-cell imaging, molecular genetics, and structural analysis will be involved.
National Institute of General Medical Sciences
4/1/1992-3/31/2007

2. Mechanism of action of the lissencephaly genes LIS-1
The lissencephalopathies are a class of human brain development diseases thought to result from defects in neuronal cell body migration. Mutations in the LIS-1 gene are responsible for Miller-Dieker Lissencephaly and Isolated Lissencephaly Sequence. The aims of this grant are to understand the role of LIS1 at the cellular and molecular level in the control of cell division and neuronal migration.
National Institute of Child and Human Development
8/01/2000-7/31/2005

Honors and Awards

1991 Fellow, AAAS
1996 NIH Merit Award
1998-2001 Council Delegate, AAAS
1999-2001 H. Arthur Smith Chair in Cancer Research

Committees, Council, Professional Society Memberships

1989- Associate Editor, Cell Motil. Cytoskel.
1986, 1991, 1998 Series Editor, Methods in Enzymology, Vol. 134, 196, and 298
1989-1993 ACS Advisory Committee on Cell and Molecular Biology
1989-1994 Editorial Board, Journal of Biological Chemistry

Keywords

dynein ATPase, neuronal transport, protein structure function, regulatory gene, Golgi apparatus, cell cycle, cytoplasm, gene expression, microtubule associated protein, organelle, phosphorylation, complementary DNA, electron microscopy, fusion gene, genetic mapping, image processing, molecular cloning, nucleic acid sequence, oligonucleotide, point mutation

top